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ABSTRACT
Background: Despite growing evidence for food-based dietary patterns’ potential to reduce cardiovascular
disease risk, knowledge about the amounts of food associated with the greatest change in risk of speciﬁc
cardiovascular outcomes and about the quality of meta-evidence is limited. Therefore, the aim of this meta-
analysis was to synthesize the knowledge about the relation between intake of 12 major food groups (whole
grains, reﬁned grains, vegetables, fruits, nuts, legumes, eggs, dairy, ﬁsh, red meat, processed meat, and sugar-
sweetened beverages [SSB]) and the risk of coronary heart disease (CHD), stroke and heart failure (HF).
Methods: We conducted a systematic search in PubMed and Embase up to March 2017 for prospective
studies. Summary risk ratios (RRs) and 95% conﬁdence intervals (95% CI) were estimated using a random
effects model for highest versus lowest intake categories, as well as for linear and non-linear relationships.
Results: Overall, 123 reports were included in the meta-analyses. An inverse association was present for
whole grains (RRCHD: 0.95 (95% CI: 0.92–0.98), RRHF: 0.96 (0.95–0.97)), vegetables and fruits (RRCHD: 0.97
(0.96–0.99), and 0.94 (0.90–0.97); RRstroke: 0.92 (0.86–0.98), and 0.90 (0.84–0.97)), nuts (RRCHD: 0.67 (0.43–
1.05)), and ﬁsh consumption (RRCHD: 0.88 (0.79–0.99), RRstroke: 0.86 (0.75–0.99), and RRHF: 0.80 (0.67–0.95)),
while a positive association was present for egg (RRHF: 1.16 (1.03–1.31)), red meat (RRCHD: 1.15 (1.08–1.23),
RRstroke: 1.12 (1.06–1.17), RRHF: 1.08 (1.02–1.14)), processed meat (RRCHD: 1.27 (1.09–1.49), RRstroke: 1.17
(1.02–1.34), RRHF: 1.12 (1.05–1.19)), and SSB consumption (RRCHD: 1.17 (1.11–1.23), RRstroke: 1.07 (1.02–1.12),
RRHF: 1.08 (1.05–1.12)) in the linear dose-response meta-analysis. There were clear indications for non-
linear dose-response relationships between whole grains, fruits, nuts, dairy, and red meat and CHD.
Conclusion: An optimal intake of whole grains, vegetables, fruits, nuts, legumes, dairy, ﬁsh, red and
processed meat, eggs and SSB showed an important lower risk of CHD, stroke, and HF.
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Background
The global challenges of cardiovascular diseases (CVD) present
an enormous health burden (Fuster and Kelly 2010). In 2015,
CVD were among the leading causes of disease burden world-
wide (Kassebaum et al. 2016). Lifestyle, especially unhealthy
dietary patterns, represents a major trigger in the development
of CVD and its associated risk factors (e.g., hypercholesterol-
emia, hypertension, and type 2 diabetes mellitus) (Moran et al.
2014; Scarborough et al. 2011; Verschuren et al. 1995). On the
other hand, healthy food and an overall balanced dietary pat-
tern may exert beneﬁcial effects on cardiovascular health.
On the basis of the current evidence, food-based priorities to
reduce CVD risk are to increase consumption of whole grains,
fruits, vegetables, legumes, nuts and seeds, and ﬁsh, to keep a
moderate dairy and vegetable oil intake, and to avoid/reduce
consumption of reﬁned grains, sugar-sweetened beverages
(SSBs), and red and processed (sodium-preserved) meats
(Anand et al. 2015; Moran et al. 2014; Mozaffarian 2016).
Thus, the United States Dietary Guidelines (healthy American
diet, the Mediterranean diet and the vegetarian diet) (USDA
2015) and scientiﬁc societies (Anderson et al. 2013; Eckel et al.
2014; Perk et al. 2012), for example, recommend dietary pat-
terns that combine these food-based recommendations regard-
ing prevention of chronic diseases.
There is growing evidence and consensus for such food-based
dietary patterns as the best means to reduce CVD, obesity,
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weight gain, and diabetes mellitus (Mozaffarian 2016). The
approach to primarily consider diet at the level of consumption
of food groups instead of nutrients and other dietary compounds
is directly linked to the concept of food-based dietary guidelines
that should be formulated for each country depending on the
current dietary practice and the level of intake (EFSA 2010). Evi-
dence for relationships between food consumption and disease
risk from meta-analyses is a key component in this process and
independent from the country-speciﬁc situation.
Even though evidence about the association of CVD risk
with some foods and food groups has been reviewed and
summarized (Eckel et al. 2014; Kromhout et al. 2016; Nordic
Council of Ministers 2014; USDA 2015), a remaining ques-
tion is which amounts of foods or food groups are associated
with the greatest change in risk of CVD (referred to herein-
after as optimal intakes), differentiated according to the sep-
arate CVD outcomes coronary heart disease (CHD), stroke,
and heart failure (HF). As previously shown, selecting spe-
ciﬁc optimal intakes among the selected food groups can
lead to a considerable change in risk of premature death
(Schwingshackl et al. 2017a) and morbidity such as type 2
diabetes (Schwingshackl et al. 2017b), and hypertension
(Schwingshackl et al. 2017c). Furthermore, trustworthiness
of meta-evidence is very rarely performed in previous meta-
analyses (Mozaffarian 2016). Consequently, one of the most
important questions that remain to be answered is which
food groups show high quality meta-evidence of protective
or detrimental associations with risk of CHD, stroke, and
HF using a comprehensive approach.
To address these issues, we conducted a systematic review
and meta-analysis of prospective studies to summarize ﬁndings
of the associations between 12 a priori deﬁned food groups,
including whole grains, reﬁned grains, vegetables, fruits, nuts,
legumes, eggs, dairy, ﬁsh, red meat, processed meat, and SSB
with risk of CHD, stroke, and HF. The focus is based on these
12 food groups since most diet quality indices/scores were based
on these (Schwingshackl and Hoffmann 2015a, 2015b; Schwing-
shackl et al. 2015), as previously reported (Schwingshackl et al.
2016a). The relation between the selected food groups and the
mentioned CVD outcomes were calculated separately given their
distinct pathogenesis and thus different risk associations between
exposure factors and individual endpoints could exist and have
to be identiﬁed (instead of adding further evidence for aggre-
gated CVD). Special attention was given to strength and dose-
speciﬁc shape of the relationship for ﬁnding an optimal intake
for lowest risk by high versus low and linear as well as non-lin-
ear dose-response meta-analyses. Finally, using the NutriGrade
scoring system, we aimed to evaluate food groups’ quality of
meta-evidence on their protective or detrimental associations
with risk of CHD, stroke, and HF, respectively.
Materials and methods
The review was registered in PROSPERO International Pro-
spective Register of Systematic Reviews (www.crd.york.ac.uk/
prospero/index.asp, identiﬁer CRD42016037069). Our strategy
for the systematic review and meta-analysis was pre-deﬁned in
a published protocol (Schwingshackl et al. 2016a) and has
already been implemented for two recently published meta-
analyses on all-cause mortality and type 2 diabetes, respectively
(Schwingshackl et al. 2017b; Schwingshackl et al. 2017a). This
systematic review was planned and conducted according to the
standards of the Meta-analysis of Observational Studies in Epi-
demiology (Stroup et al. 2000).
Search strategy
Literature search was performed using the electronic data-
bases PubMed (until March 2017) and Embase (until
March 2017), with no restriction to language and calendar
date using the search terms described in Supplementary
Appendix 1.
Additionally, the reference lists from the retrieved articles were
checked to identify further relevant studies. Published systematic
reviews and meta-analyses were also used as a data source. Litera-
ture search was conducted by two authors (AB, LS), with disagree-
ment resolved by consensus of another reviewer (HB).
Study selection
Studies were included in the meta-analysis if they met all of the
following criteria: (1) prospective design (cohort studies, case-
cohort studies, nested case-control studies, follow-up studies of
RCTs); (2) information about the association for at least one of
the following 12 food groups: whole grains/cereals, reﬁned
grains/cereals, vegetables, fruits, nuts, legumes, eggs, dairy
products, ﬁsh, red meat, processed meat, SSB; (3) Participants
aged 18 years; and (4) considering CHD including myocar-
dial infarction and other coronary artery diseases (like angina);
stroke (haemorrhagic, ischemic); and HF as outcomes. Exclu-
sion criteria were (1) studies including populations suffering
from chronic disease; (2) studies reporting only fatal outcomes,
since mortality was included in a previous meta-analysis
(Schwingshackl et al. 2017c); (3) studies aggregating outcomes
as total CVD, and not reporting on CHD, stroke or HF sepa-
rately; (4) when a study appeared to have been published in
duplicate, the version containing the longest follow-up was
selected.
Data extraction
Two authors (AB, LS) extracted the following characteristics:
the ﬁrst author’s last name, year of publication, study origin,
cohort name, sample size, number of cases, age at entry, sex,
study length (follow-up in years), outcome, outcome assess-
ment, assessment of food group, quantity of food, risk estimate
(most adjusted measures) (hazard ratios (HR), risk ratios (RR),
or odds ratios (OR) with their corresponding 95% conﬁdence
intervals (CIs)), and adjustment factors.
When a study provided several risk estimates, the multivariable
model was chosen.When only separate risk estimates for male and
female participants were available in a study, we combined the RRs
using a ﬁxed effect model before inclusion in themeta-analysis.
Risk of bias assessment
To assess the risk of bias of the prospective studies, we assessed
ascertainment of exposure (low risk of bias: validated,
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calibrated FFQ or 24-h recall, diet history, or diet records (mul-
tiple days)), assessment of outcome (low risk of bias: record
linkage (ICD codes), accepted clinical criteria, self-reported
and validated), duration of follow-up (<10 versus 10 years),
and whether basic model was adjusted and outcome relevant
adjustments (age, sex, education, body mass index, smoking,
physical activity, energy intake) were made (Schwingshackl
et al. 2016c). Studies were classiﬁed as being at low risk of bias
in general only if none of the domains established a high
/unclear risk of bias.
Statistical analysis
For high versus low and dose-response meta-analyses, a ran-
dom effects model was used to calculate summary RRs/HRs/
ORs and 95% CIs summarizing associations between the food
groups (whole grains/cereals, reﬁned grains/cereals, vegetables,
fruits, nuts, legumes, eggs, dairy products, ﬁsh, red meat, proc-
essed meat, SSB), and risk of CHD, stroke, and HF (DerSimo-
nian and Laird 1986), which incorporated both within and
between study variability. Meta-analysis was based on the
assumption that all measures are RRs. To evaluate the weight-
ing of each study, the standard error for the log-transformed
RR of each study was calculated and regarded as the estimated
variance of the log-transformed RR, using an inverse variance
method (DerSimonian and Laird 1986).
The method described by Greenland and Longnecker
(Greenland and Longnecker 1992) was applied for the dose-
response analysis and computed study-speciﬁc slopes (linear
trends) and corresponding 95% CIs from the natural logs of
the RRs and CIs across intake categories of the 12 food groups.
The method requires that the distribution of cases, person-
years or non-cases, and the RRs with the 95% CI for at least
three quantitative exposure categories are known.
When studies reported only the total number of cases or
total person-years and the exposure was deﬁned in quantiles,
the distribution of cases or person-years was calculated by
dividing the total number by the number of quantiles, thus
assuming an equal distribution across exposure quantiles.
Whenever reported, the mean or median intake by category
was assigned to the corresponding RR. The midpoint was cal-
culated for studies that only reported a range of intake by cate-
gory. When the intake range was open-ended, we assumed that
its width was the same as the adjacent category. For studies pre-
senting the exposure per given unit of energy intake, we
rescaled it using the mean energy intake provided.
Where studies had already reported a linear dose-response
trend, with CI or standard error, this was used directly.
The units of exposure were deﬁned as follows: whole grains/
cereals (30 g/d), reﬁned grains/cereals (30 g/d), vegetables
(100 g/d), fruits (100 g/d), nuts (28 g/d), legumes (50 g/d), eggs
(50 g/d), dairy products (200 g/d), ﬁsh (100 g/d), red meat
(100 g/d), processed meat (50 g/d), and sugar sweetened bever-
ages (250ml/d). For studies that reported intake only as serving
size (and did not specify the quantitative amount), we used rec-
ommended conversions (WCRF 2017) (Supplemental Table 1).
To examine possible non-linear associations, we calculated
restricted cubic splines for each study with more than three cat-
egories of exposure, using three ﬁxed knots at 10%, 50%, and
90% through the total distribution of the reported intake, and
combined them using multivariable meta-analysis (Durrleman
and Simon 1989) (if at least 2 studies with at least three quanti-
tative exposure levels were known for one of the 12 food groups
with the corresponding outcome).
Moreover, the risk reduction potential of foods was calcu-
lated by multiplying the RR by selecting an optimal consump-
tion of risk-reducing foods (calculated by 1¡RRreduced), and
risk-increasing foods noted as .calculated by 1¡ 1RRincreased /:
The optimal consumption was deﬁned as the serving category
of a single food group with the strongest association for CHD,
stroke, and HF risk, respectively.
To explore heterogeneity between studies, we used
Cochran’s Q test and calculated the I2 statistic (with a value of
I2 > 50% considered to represent potentially important statisti-
cal heterogeneity) (Higgins and Thompson 2002). In addition,
to identify potential sources of heterogeneity, we stratiﬁed the
meta-analysis by subgroups. If more than ﬁve studies were
available for a food group in the highest vs. lowest category
meta-analysis or in the linear dose-response analysis, subgroup
analyses were performed by the following characteristics: sex,
length of follow-up (mean or median 10 years vs. <10 years),
geographic location (Europe, America, Asia and Australia),
number of cases (1,000 vs. <1,000), and dietary assessment
(validated vs. non-validated). Furthermore, we performed sen-
sitivity analyses for low risk of bias studies, excluding nested
case-control studies and studies based on ORs.
Potential small-study effects, such as publication bias, were
explored using Eggers test and funnel plots (Egger et al. 1997),
if at least 10 studies were available (Higgins and Green 2011).
Review Manager 5.3 (Nordic Cochrane Center, Copenha-
gen), and Stata version 14 software (StataCorp, College Station,
TX) were used for the statistical analyses.
Quality of meta-evidence
Quality of evidence of the meta-analyses (i.e., meta-evidence)
was deﬁned as the conﬁdence in the estimate. To evaluate the
meta-evidence for the association between the 12 pre-deﬁned
food groups and CHD, stroke, and HF risk, we applied the
NutriGrade scoring system (max 10 points) which comprises
the following items: (i) risk of bias/study quality/study limita-
tions (max. 2 points), (ii) precision (max. 1 point), (iii) hetero-
geneity (max. 1 point), (iv) directness (max. 1 point), (v)
publication bias (max. 1 point), (vi) funding bias (max. 1
point), (vii) effect size (max. 2 points), and (viii) dose-response
(max. 1 point) (Schwingshackl et al. 2016c). Based on this scor-
ing system we deﬁned four meta-evidence levels: high (8
points), moderate (6-<8 points), low (4-<6 points), and very
low (0-<4 points).
Results
Out of the 16,623 records which were identiﬁed by the system-
atic literature search, 261 full text articles were assessed in detail
as they reported on at least one of the 12 food groups and CVD
outcomes in the title/abstract (Figure 1; Supplemental
Appendix 2).
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Sixteen prospective studies were included in the meta-analysis
for consumption of whole grains (16 reports) (Del Gobbo et al.
2015; Djousse and Gaziano 2007; Hansen et al. 2017; Helnaes
et al. 2016; Jensen et al. 2004; Liu et al. 2000b; Liu et al. 1999;
Mizrahi et al. 2009; Muraki et al. 2015; Neelakantan et al. 2016;
Nettleton et al. 2008; Rautiainen et al. 2012; Sonestedt et al. 2015;
Steffen et al. 2003; Tektonidis et al. 2015, 2016) (Supplemental
Table 2), 9 studies for reﬁned grains (8 reports) (Djousse and
Gaziano 2007; Eshak et al. 2014; Liu et al. 2000b; Mizrahi et al.
2009; Muraki et al. 2015; Sonestedt et al. 2015; Steffen et al. 2003;
Yu et al. 2013) (Supplemental Table 3), 35 for vegetables
(32 reports) (Belin et al. 2011a; Bendinelli et al. 2011;
Bhupathiraju et al. 2013; Buckland et al. 2009; Dauchet et al.
2004; Del Gobbo et al. 2015; Dilis et al. 2012; Gillman et al. 1995;
Hansen et al. 2017; Hansen et al. 2010; Hirvonen et al. 2001;
Johnsen et al. 2003; Joshipura et al. 1999; Keli et al. 1996;
Kobylecki et al. 2015; Larsson et al. 2009b; Larsson et al. 2013;
Lin et al. 2013; Liu et al. 2001; Liu et al. 2000a; Martinez-Gonza-
lez et al. 2011; Misirli et al. 2012; Mizrahi et al. 2009; Neelakantan
et al. 2016; Oude Griep et al. 2012; Rautiainen et al. 2015; Sones-
tedt et al. 2015; Tognon et al. 2014; Wurtz et al. 2016; Yokoyama
et al. 2000; Yu et al. 2014; Zhang et al. 2011) (Supplemental
Table 4), 32 for fruits (30 reports) (Belin et al. 2011a; Bendinelli
et al. 2011; Bhupathiraju et al. 2013; Buckland et al. 2009;
Dauchet et al. 2004; Del Gobbo et al. 2015; Du et al. 2016; Fraser
et al. 1992; Gillman et al. 1995; Hansen et al. 2017; Hansen et al.
2010; Hirvonen et al. 2001; Johnsen et al. 2003; Joshipura et al.
1999; Keli et al. 1996; Kobylecki et al. 2015; Larsson et al. 2009b;
Larsson et al. 2013; Lin et al. 2013; Liu et al. 2000a; Mizrahi et al.
2009; Neelakantan et al. 2016; Oude Griep et al. 2012; Rautiainen
et al. 2015; Sonestedt et al. 2015; Tognon et al. 2014; Yamada
et al. 2011; Yokoyama et al. 2000; Yu et al. 2014; Zhang et al.
2011) (Supplemental Table 5), 13 for nuts (12 reports) (Albert
et al. 2002; Bernstein et al. 2012b; Bernstein et al. 2010; Del
Gobbo et al. 2015; di Giuseppe et al. 2015; Djousse et al. 2010;
Djousse et al. 2008; Fraser et al. 1992; Haring et al. 2014; Haring
et al. 2015; Nettleton et al. 2008; Yaemsiri et al. 2012) (Supple-
mental Table 6), 15 for legumes (13 reports) (Bazzano et al. 2001;
Bernstein et al. 2012b; Bernstein et al. 2010; Buckland et al. 2009;
Dilis et al. 2012; Fraser et al. 1992; Haring et al. 2014; Haring
et al. 2015; Kokubo et al. 2007; Martinez-Gonzalez et al. 2011;
Misirli et al. 2012; Mizrahi et al. 2009; Yu et al. 2014) (Supple-
mental Table 7), 17 for eggs (16 reports) (Bernstein et al. 2012b;
Bernstein et al. 2010; Burke et al. 2007; Dilis et al. 2012; Djousse
Figure 1. Flow chart of study selection.
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and Gaziano 2008a, 2008b; Goldberg et al. 2014; Haring et al.
2014; Haring et al. 2015; Hu et al. 1999; Larsson et al. 2015; Mis-
irli et al. 2012; Nettleton et al. 2008; Qureshi et al. 2007; Virtanen
et al. 2016; Yaemsiri et al. 2012) (Supplemental Table 8), 24 for
dairy products (24 reports) (Avalos et al. 2013; Bergholdt et al.
2015; Bernstein et al. 2012b; Bernstein et al. 2010; Buckland et al.
2009; Dalmeijer et al. 2013; Dilis et al. 2012; Elwood et al. 2004;
Fraser et al. 1992; Haring et al. 2014; Haring et al. 2015; Larsson
et al. 2009a; Larsson et al. 2012; Lin et al. 2013; Martinez-Gonza-
lez et al. 2011; Misirli et al. 2012; Nettleton et al. 2008; Patterson
et al. 2013; Praagman et al. 2015; Soedamah-Muthu et al. 2013;
Sonestedt et al. 2011; Tektonidis et al. 2015, 2016; Yaemsiri et al.
2012) (Supplemental Table 9), 47 for ﬁsh (47 reports) (Albert
et al. 1998; Amiano et al. 2016a; Ascherio et al. 1995; Atkinson
et al. 2011; Belin et al. 2011b; Bernstein et al. 2012b; Bernstein
et al. 2010; Bjerregaard et al. 2010; Buckland et al. 2009; de Goede
et al. 2010; de Goede et al. 2012; Del Gobbo et al. 2015; Dijkstra
et al. 2009; Dilis et al. 2012; Fraser et al. 1992; Gammelmark et al.
2016; Gillum et al. 2000; Gillum et al. 1996; Hansen et al. 2017;
Haring et al. 2014; Haring et al. 2015; Holmberg et al. 2009; Iso
et al. 2006; Keli et al. 1994; Kuhn et al. 2013; Larsson et al. 2011a;
Levitan et al. 2009, 2010; Martinez-Gonzalez et al. 2011; Misirli
et al. 2012; Montonen et al. 2009; Morris et al. 1995; Mozaffarian
et al. 2005a; Mozaffarian et al. 2003; Mozaffarian et al. 2005b;
Myint et al. 2006; Nahab et al. 2016; Nettleton et al. 2008; Oren-
cia et al. 1996; Osler et al. 2003; Salonen et al. 1995; Tektonidis
et al. 2015; Tognon et al. 2014; Wennberg et al. 2011; Wennberg
et al. 2007; Wilk et al. 2012; Wurtz et al. 2016) (Supplemental
Table 10), 15 for red meat (Amiano et al. 2016b; Ashaye et al.
2011; Bernstein et al. 2012b; Bernstein et al. 2010; Del Gobbo
et al. 2015; Fraser et al. 1992; Haring et al. 2014; Haring et al.
2015; Kaluza et al. 2014, 2015; Larsson et al. 2011b, 2011c; Nettle-
ton et al. 2008; Wurtz et al. 2016; Yaemsiri et al. 2012) (Supple-
mental Table 11), 14 for processed meat (13 reports) (Amiano
et al. 2016b; Ascherio et al. 1994; Bernstein et al. 2012b; Bernstein
et al. 2010; Burke et al. 2007; Del Gobbo et al. 2015; Haring et al.
2014; Haring et al. 2015; Kaluza et al. 2014, 2015; Larsson et al.
2011b, 2011c; Wurtz et al. 2016) (Supplemental Table 12), and
11 for SSB (9 reports) (Bernstein et al. 2012a; de Koning et al.
2012; Del Gobbo et al. 2015; Eshak et al. 2012; Fung et al. 2009;
Gardener et al. 2012; Larsson et al. 2014; Rahman et al. 2015;
Sonestedt et al. 2015) (Supplemental Table 13).
Whole grains
For whole grains, 7 studies with 6,834 cases were included in
the high vs. low intake meta-analysis (overall intake range:
0–220 g/d) for CHD, 7 studies with 11,114 cases (overall intake
range: 0–670 g/d) for stroke, and 5 studies with 6,455 cases
(overall intake range: 0–280 g/d) for HF.
Comparing the highest to the lowest categories of whole
grain intake, inverse associations with risk of CHD (RR: 0.85;
95% CI 0.81 to 0.90, I2 D 0%, pheterogeneity D 0.72), stroke (RR:
0.91; 95% CI 0.82 to 1.02, I2 D 53%, pheterogeneity D 0.05), and
HF (RR: 0.91; 95% CI 0.85 to 0.97, I2 D 35%, pheterogeneity D
0.19) were observed (Supplemental Figure 1).
Each additional daily 30 g of whole grains were inversely asso-
ciated with risk of CHD (RR: 0.95; 95% CI 0.92 to 0.98, I2 D
46%, pheterogeneity D 0.11, n D 5) and HF (RR: 0.96; 95% CI 0.95
to 0.97, I2 D 0%, pheterogeneity D 0.36, n D 2), but not with risk of
stroke (RR: 0.99; 95% CI 0.95 to 1.03, I2 D 65%, pheterogeneity D
0.04, nD 4) (Supplemental Figure 2).
Heterogeneity observed in the high vs. low whole grain
intake meta-analysis for stroke persisted in stratiﬁed analyses
(Supplemental Table 14a-b) and, where detectable, no evidence
of heterogeneity for subgroup-differences was observed.
There was evidence of a non-linear dose-response associa-
tion (pnon-linearity<0.001, n D 5 studies) for CHD, but not for
stroke (pnon-linearity D 0.77, n D 3 studies). The risk of CHD
decreased by 17% with increasing intake of whole grains up to
»100 g/d. No beneﬁt for increasing intake was apparent above
this intake (Figure 2). No association was observed for whole
grain intake and risk of stroke in the non-linear dose-response
analysis (Figure 3).
Reﬁned grains
Five studies with 3,286 cases were included in the high vs. low
intake meta-analysis (overall intake range: 15–540 g/d) for
CHD, 6 studies with 11,434 cases (overall intake range: 15–
540 g/d) for stroke, and 1 study with 1018 cases (overall intake
range: 0–40 g/d) for HF.
Comparing the highest to the lowest categories of intake, a
trend for a positive association between risk of CHD (RR: 1.11;
95% CI 0.99 to 1.25, I2 D 0%, pheterogeneity D 0.52) and reﬁned
grain intake was observed, whereas no association was detected
for stroke (RR: 1.02; 95% CI 0.94 to 1.11, I2 D 2%, pheterogeneity
D 0.41), or HF (RR: 0.83; 95% CI 0.58 to 1.19) (Supplemental
Figure 3).
No association was observed for each additional daily 30 g of
reﬁned grains and risk of CHD (RR: 1.01; 95% CI 0.99 to 1.04,
I2 D 0%, pheterogeneity D 0.51, n D 4), stroke (RR: 1.00; 95% CI
0.98 to 1.01, I2 D 0%, pheterogeneity D 0.51, n D 4), or HF (RR:
0.86; 95% CI 0.68 to 1.09, n D 1) (Supplemental Figure 4).
No evidence of heterogeneity was detected between sub-
groups in stratiﬁed analyses (high vs. low meta-analysis) on
reﬁned grains and stroke (Supplemental Table 15).
There was no evidence of a non-linear dose-response associ-
ation between reﬁned grains and CHD (pnon-linearity D 0.25,
n D 4 studies), or stroke (pnon-linearity D 0.42, n D 4 studies)
(Figure 2 and 3).
Vegetables
Nineteen studies with 19,402 cases were included in the high vs.
low intake meta-analysis for vegetables and CHD (overall
intake range: 0–1,300 g/d), 16 studies with 12,442 cases for
stroke (overall intake range: 0–500 g/d), and 3 studies with
6,267 cases for HF (overall intake range: 100–460 g/d).
Comparing the highest to the lowest categories of vegetable
intake, an inverse association was observed for risk of CHD (RR:
0.92; 95% CI 0.87 to 0.98, I2D 42%, pheterogeneityD 0.03) and stroke
(RR: 0.87; 95% CI 0.82 to 0.93, I2D 38%, pheterogeneityD 0.06), while
no association was observed for risk of HF (RR: 0.99; 95% CI 0.82
to 1.18, I2D 80%, pheterogeneityD 0.007) (Supplemental Figure 5).
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Each additional daily 100 g of vegetables were inversely
associated with risk of CHD (RR: 0.97; 95% CI 0.96 to 0.99,
I2 D 12%, pheterogeneity D 0.32, n D 14), stroke (RR: 0.92;
95% CI 0.86 to 0.98, I2 D 79%, pheterogeneity<0.001, n D 10),
and HF (RR: 0.96; 95% CI 0.94 to 0.98, n D 1) (Supplemen-
tal Figure 6).
No evidence of heterogeneity was detected between sub-
groups in stratiﬁed analyses (high vs. low meta-analysis) on
vegetables and CHD and stroke (Supplemental Table 16a-
b). In stratiﬁed analyses (dose-response meta-analysis) the
inverse association between vegetable intake and CHD risk
was no longer signiﬁcant in men, in studies conducted in
Europe, Asia and Australia, in smaller studies (<1,000
cases), and studies using non-validated dietary assessment
methods, possibly due to limited number of studies (Supple-
mental Table 16c). The heterogeneity of studies included in
dose-response analysis on vegetable intake and stroke per-
sisted in additional analyses stratiﬁed by subgroups
(Supplemental Table 16d). Evidence for an inverse associa-
tion was observed in men (no studies in women only), in
long-term and European, Asian and Australian studies. No
evidence of heterogeneity was detected between subgroups
in stratiﬁed analyses.
There was evidence for small study effects in the high vs. low
(p D 0.03), but not in the dose-response analysis for CHD. No
evidence for small study effects was observed for stroke. Visual
inspection of the funnel plots (dose-response analysis) sug-
gested little asymmetry for CHD (Supplemental Figure 25), but
not for stroke (Supplemental Figure 26).
There was no evidence of a non-linear dose-response associ-
ation for CHD (pnon-linearity D 0.19, n D 13 studies), but there
was for stroke (pnon-linearity D 0.03, n D 8 studies). The risk of
CHD and stroke decreased by approximately 12% with increas-
ing intake of vegetables up to »400 g/d. Additional beneﬁt for
increasing intake is apparent above this value for CHD but not
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Figure 2. Non-linear dose-response relationship between daily intakes whole grains (p for non-linearity <0.001; n D 5 studies), reﬁned grains (p for non-linearity D 0.25;
n D 4 studies), vegetables (p for non-linearity D 0.19; n D 13 studies), fruits (p for non-linearity <0.001; n D 12 studies), nuts (p for non-linearity <0.001; n D 4 studies),
legumes (p for non-linearityD 0.07; nD 8 studies), eggs (p for non-linearityD 0.81; nD 9 studies), dairy (p for non-linearity<0.01; nD 9 studies), ﬁsh (p for non-linearity
D 0.10; nD 15 studies), red meat (p for non-linearity<0.01; nD 2 studies), processed meat (p for non-linearityD 0.41; nD 2 studies), and sugar sweetened beverages (p
for non-linearityD 0.83; n D 4 studies) and risk of coronary heart disease.
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Fruits
Seventeen studies with 17,827 cases were included in the high
vs. low intake meta-analysis for fruits and CHD (overall intake
range: 0–1,820 g/d), 17 studies with 30,523 cases for stroke
(overall intake range: 0–595 g/d), and 3 studies with 6,267 cases
for HF (overall intake range: 50–300 g/d) for HF.
Comparing the highest to the lowest categories of fruit
intake, an inverse association was observed for risk of CHD
(RR: 0.89; 95% CI 0.84 to 0.93, I2 D 10%, pheterogeneity D 0.34),
stroke (RR: 0.83; 95% CI 0.77 to 0.89, I2 D 40%, pheterogeneity D
0.05), and risk of HF (RR: 0.95; 95% CI 0.88 to 1.02, I2 D 0%,
pheterogeneity D 0.73) (Supplemental Figure 7).
Each additional daily 100 g of fruits were inversely associated
with risk of CHD (RR: 0.94; 95% CI 0.90 to 0.97, I2 D 71%,
pheterogeneity<0.001, n D 13) and stroke (RR: 0.90; 95% CI 0.84 to
0.97, I2D 86%, pheterogeneity<0.001, nD 10), but not with risk of HF
(RR: 0.98; 95% CI 0.94 to 1.01, nD 1) (Supplemental Figure 8).
No evidence of heterogeneity was detected between sub-
groups in stratiﬁed analyses (high vs. low meta-analysis) on
fruits and CHD (Supplemental Table 17a), whereas some evi-
dence of heterogeneity was observed for stroke (follow-up and
geographic location) (Supplemental Table 17b). In analyses
stratiﬁed by subgroups (dose-response meta-analysis), the
inverse association between fruit intake and CHD risk was not
observed in studies including only women, in European, Asian
and Australian studies, in studies with <1,000 cases, and stud-
ies using non-validated dietary assessment (Supplemental
Table 17c). These subgroup-differences were not statistically
signiﬁcant, with one exception; after stratiﬁcation by included
number of cases, heterogeneity was observed (borderline signif-
icant p D 0.05), showing an inverse association between fruit
intake and risk of CHD only for studies including 1,000 cases.
Referring to stroke, we observed evidence of heterogeneity in
subgroups stratiﬁed for geographical location, showing greatest
risk reduction for studies conducted in Asia and Australia
(Supplemental Table 17d).
There was evidence for small study effects, in the high vs.
low (p D 0.08) analysis for stroke, and in the dose-response
analysis for CHD (p D 0.04). Visual inspection of the funnel
Figure 3. Non-linear dose-response relationship between daily intakes whole grains (p for non-linearityD 0.77; nD 3 studies), reﬁned grains (p for non-linearityD 0.42; n
D 4 studies), vegetables (p for non-linearity D 0.03; n D 8 studies), fruits (p for non-linearity D 0.54; n D 8 studies), nuts (p for non-linearity D 0.05; n D 5 studies),
legumes (p for non-linearityD 0.08; n D 5 studies), eggs (p for non-linearityD 0.39; n D 9 studies), dairy (p for non-linearityD 0.71; n D 8 studies), ﬁsh (p for non-linear-
ity D 0.37; n D 15 studies), red meat (p for non-linearity D 0.91; n D 6 studies), processed meat (p for non-linearity D 0.65; n D 6 studies), and sugar sweetened bever-
ages (p for non-linearityD 0.83; n D 6 studies) and risk of stroke.
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plots (dose-response analysis) suggested little symmetry (Sup-
plemental Figure 27 and 28).
There was evidence of a non-linear dose-response association
for CHD (pnon-linearity<0.001, n D 12 studies), but not for stroke
(pnon-linearity D 0.54, n D 8 studies). The risk of CHD and stroke
decreased by approximately 15% and 20% with increasing intake
of fruits up to »200 g/d, respectively. No beneﬁt for increasing
intake was apparent above this value (Figure 2 and 3).
Nuts
Four studies with 5,480 cases were included in the high vs. low
intake meta-analysis for nuts and CHD (overall intake range:
0–28 g/d), 6 studies with 7,490 cases for stroke (overall intake
range: 0–38 g/d) and 3 studies with 3,613 cases for HF (overall
intake range: 0–30 g/d).
Comparing the highest to the lowest categories of nut intake
revealed a trend for an inverse association between nut intake
and risk of CHD (RR: 0.80; 95% CI 0.62 to 1.03, I2 D 79%,
pheterogeneity D 0.002), which was not present in the case of stroke
(RR: 0.94; 95% CI 0.85 to 1.05, I2 D 18%, pheterogeneity D 0.30)
and HF (RR: 0.99; 95% CI 0.86 to 1.15, I2 D 57%, pheterogeneity D
0.10) (Supplemental Figure 9).
An inverse association was observed for each additional daily
28 g of nuts and risk of CHD (RR: 0.67; 95% CI 0.43 to 1.05,
I2 D 85%, pheterogeneity D 0.001, n D 4), but not for stroke (RR:
0.99; 95% CI 0.84 to 1.17, I2 D 45%, pheterogeneity D 0.11, n D 6)
or HF (RR: 1.09; 95% CI 0.97 to 1.22, I2 D 0%, pheterogeneity D
0.79, n D 2) (Supplemental Figure 10).
No important evidence of heterogeneity was detected
between subgroups in stratiﬁed analyses on nut consumption
and risk of stroke in the categorical and dose-response meta-
analysis (Supplemental Table 18a-b).
There was evidence of a non-linear dose-response associa-
tion for CHD (pnon-linearity<0.001, n D 4 studies) and stroke
(pnon-linearity D 0.05, n D 5 studies). The risk of CHD decreased
by approximately 21% with increasing intake of nuts up
to »10-15 g/d. No beneﬁt for increasing intake was apparent
above this value (Figure 2). No association was observed for
nut intake and risk of stroke in the non-linear dose-response
analysis (Figure 3).
Legumes
For legumes, 10 studies with 8,228 cases were included in the
high vs. low intake meta-analysis for CHD (overall intake
range: 0–230 g/d), and 6 studies with 6,333 cases for stroke
(overall intake range: 0–60 g/d). No study was available on HF.
Comparing the highest to the lowest categories of legume
intake, an inverse association between legume intake and risk of
CHD (RR: 0.91; 95% CI 0.84 to 0.99, I2 D 33%, pheterogeneity D
0.14), but not with risk of stroke (RR: 0.98; 95% CI 0.88 to 1.10,
I2 D 56%, pheterogeneity D 0.04) was observed (Supplemental
Figure 11).
A small inverse association was observed for each additional
daily intake of 50 g of legumes and risk of CHD (RR: 0.96; 95%
CI 0.92 to 1.01, I2 D 39%, pheterogeneity D 0.12, n D 8), but not for
stroke (RR: 1.00; 95% CI 0.88 to 1.13, I2 D 62%, pheterogeneity D
0.02, n D 6) (Supplemental Figure 12).
No association was observed in any of the stratiﬁed analyses,
neither for CHD nor for stroke (Supplemental Table 19a-d).
No evidence for small study effects was observed in the high
vs. low intake analysis of legumes and risk of CHD. Some evi-
dence of a non-linear dose-response association was observed
for CHD (pnon-linearity D 0.07, n D 8 studies), but not for stroke
(pnon-linearity D 0.08, n D 5 studies). The risk of CHD decreased
by approximately 10% with increasing intake of legumes up to
»100 g/d (Figure 2). No beneﬁt for increasing intake was
apparent above this value (Figure 2). No association was
observed for legume intake and risk of stroke in the non-linear
dose-response analysis (Figure 3).
Eggs
For eggs, 11 studies with 14,370 cases were included in the high
vs. low intake meta-analysis (overall intake range: 0–75 g/d) for
CHD, 10 studies with 12,735 cases (overall intake range: 0–
75 g/d) for stroke, and 4 studies with 5,059 cases (overall intake
range: 0–140 g/d) for HF.
Comparing the highest to the lowest categories of egg intake,
no association between egg intake and risk of CHD (RR: 0.99;
95% CI 0.94 to 1.05, I2D 0%, pheterogeneityD 0.49) or risk of stroke
(RR: 0.99; 95% CI 0.93 to 1.05, I2 D 3%, pheterogeneity D 0.41) was
observed. A positive association between egg intake and risk of
HF (RR: 1.25; 95% CI 1.12 to 1.39, I2 D 0%, pheterogeneity D 0.46)
was detected (Supplemental Figure 13).
In the dose-response meta-analysis, there was no association
between each increment of 50 g of daily egg intake and risk of
CHD (RR: 1.00; 95% CI 0.95 to 1.06, I2 D 0%, pheterogeneity D
0.93, n D 9) or stroke (RR: 0.99; 95% CI 0.93 to 1.05, I2 D 0%,
pheterogeneity D 0.44, n D 10), but with risk of HF (RR: 1.16; 95%
CI 1.03 to 1.31, I2 D 55%, pheterogeneity D 0.08, n D 4) (Supple-
mental Figure 14).
No association was observed in any of the stratiﬁed analyses,
neither for eggs and CHD nor for eggs and stroke (Supplemen-
tal Table 20a-d).
No evidence for small study effects was observed in the
high vs. low intake meta-analysis for eggs and CHD, as was
also the case for stroke both in the high vs. low and dose-
response analysis. Visual inspection of the funnel plots
(dose-response analysis) suggests moderate asymmetry (Sup-
plemental Figure 29).
There was no evidence of a non-linear dose-response associ-
ation for CHD (pnon-linearity D 0.81, n D 9 studies), and stroke
(pnon-linearity D 0.39, n D 9 studies) (Figure 2 and 3), but there
was for HF (pnon-linearity D 0.04, n D 3 studies). The risk of HF
increased by approximately 50% with increasing intake of egg
up to »100 g/d (Supplemental Figure 34). No association was
observed for egg intake and risk of CHD and stroke in the non-
linear dose-response analysis.
Dairy
Thirteen studies with 15,790 cases were included in the high vs.
low intake meta-analysis for dairy and CHD (overall intake
range: 0–3,000 g/d), 12 studies with 16,887 cases for stroke
(overall intake range: 0–1,860 g/d), and 3 studies with 4,057
cases for HF (overall intake range: 0–1,390 g/d).
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Comparing the highest to the lowest categories of dairy intake,
no associations between dairy intake and risk of CHD (RR: 0.99;
95% CI 0.92 to 1.07, I2 D 59%, pheterogeneity D 0.004), stroke (RR:
0.96; 95% CI 0.90 to 1.01, I2 D 43%, pheterogeneity D 0.05), or HF
(RR: 1.00; 95% CI 0.90 to 1.10, I2 D 67%, pheterogeneity D 0.05)
were observed (Supplemental Figure 15).
Each additional daily 200 g of dairy were not associated
with risk of CHD (RR: 0.99; 95% CI 0.96 to 1.02, I2 D 55%,
pheterogeneity D 0.02, n D 10) or stroke (RR: 0.98; 95% CI 0.96 to
1.00, I2 D 50%, pheterogeneity D 0.03, n D 11), but were positively
associated with risk of HF (RR: 1.08; 95% CI 1.01 to 1.15,
n D 1) (Supplemental Figure 16).
No association between dairy intake and risk of CHD was
observed in any of the stratiﬁed analyses (Supplemental
Table 21a and c). Referring to stroke, we observed heterogene-
ity in subgroups stratiﬁed for sex (dose-response) and geo-
graphical location, showing an inverse association in women
and in American studies only (Supplemental Table 21b and d).
Comparing low-fat and high-fat dairy products, no signiﬁ-
cant differences could be observed for CHD and stroke.
There was no evidence of small study effects in the high vs.
low and dose-response meta-analysis for dairy and CHD, and
for dairy and stroke. Visual inspection of the funnel plots
(dose-response analysis) suggests moderate symmetry (Supple-
mental Figure 30 and 31).
There was evidence of a non-linear dose-response associa-
tion between dairy products and CHD (pnon-linearity<0.01, n D
9 studies), but not for stroke (pnon-linearity D 0.71, nD 8 studies).
The risk of stroke decreased by approximately 5% with increas-
ing intake of dairy up to »500 g/d (Figure 3), whereas no asso-
ciation was observed for CHD (Figure 2).
Fish
For ﬁsh, 22 studies with 16,732 cases were included in the high vs.
low intake meta-analysis (overall intake range: 0–320 g/d) for
CHD, 20 studies with 14,360 cases (overall intake range: 0–130 g/
d) for stroke, and 8 studies with 7,945 cases (overall intake range:
0–80 g/d) for HF.
Comparing the highest to the lowest categories, a small
inverse association between ﬁsh intake and risk of CHD (RR:
0.94; 95% CI 0.88 to 1.02, I2 D 52%, pheterogeneity D 0.003) or
stroke (RR: 0.95; 95% CI 0.89 to 1.01, I2 D 37%, pheterogeneity D
0.05), and a stronger inverse association between ﬁsh intake
and risk of HF (RR: 0.89; 95% CI 0.80 to 0.99, I2 D 18%, phetero-
geneity D 0.29) was observed (Supplemental Figure 17).
Each additional daily 100 g of ﬁsh were inversely associated
with risk of CHD (RR: 0.88; 95% CI 0.79 to 0.99, I2 D 40%,
pheterogeneity D 0.06, n D 15), stroke (RR: 0.86; 95% CI 0.75 to
0.99, I2 D 25%, pheterogeneity D 0.18, n D 15), and HF (RR: 0.80;
95% CI 0.67 to 0.95, I2 D 20%, pheterogeneity D 0.28, n D 7)
(Supplemental Figure 18).
No important evidence of heterogeneity was detected
between subgroups in stratiﬁed analyses (high vs. low meta-
analysis) on ﬁsh consumption and risk of CHD and stroke
(Supplemental Table 22a-b). We observed heterogeneity in sub-
groups (dose-response meta-analysis) stratiﬁed for sex, show-
ing an inverse association between ﬁsh intake and CHD solely
in the study including women only (Supplemental Table 22c).
Referring to stroke (dose-response meta-analysis), there was an
inverse association observed in studies including women only,
long-term studies and studies using validated dietary assess-
ment (Supplemental Table 22d). These subgroup-differences
were not statistically signiﬁcant.
There was no evidence of small study effects in the high vs.
low analysis for CHD or in the dose-response meta-analysis for
CHD and stroke, but there was in the high vs. low analysis for
stroke (p D 0.07). Visual inspection of the funnel plots (dose-
response analysis) suggests little symmetry (Supplemental
Figure 32 and 33).
There was no evidence of a non-linear dose-response associa-
tion between ﬁsh intake and CHD (pnon-linearity D 0.10, n D 15
studies), stroke (pnon-linearity D 0.37, n D 15 studies), or HF (pnon-
linearity D 0.14, n D 6 studies). The risk of CHD decreased by
approximately 15% with increasing intake of ﬁsh up to »250 g/d
(Figure 2), whereas the risk of stroke and HF decreased by approx-
imately 10 and 20% with increasing intake of ﬁsh up to »80–
100 g/d, respectively (Figure 3 and Supplemental Figure 35).
Red meat
For red meat, 3 studies with 6,659 cases were included in the
high vs. low intake meta-analysis (overall intake range: 9–
205 g/d) for CHD, 7 studies with 10,541 cases (overall intake
range: 6–195 g/d) for stroke, and 5 studies with 9,229 cases
(overall intake range: 0–175 g/d) for HF.
Comparing the highest to the lowest categories, a positive
association between red meat intake and risk of CHD (RR:
1.16; 95% CI 1.08 to 1.24, I2 D 0%, pheterogeneity D 0.89), stroke
(RR: 1.16; 95% CI 1.08 to 1.25, I2 D 0%, pheterogeneity D 0.69),
and HF (RR: 1.12; 95% CI 1.04 to 1.21, I2 D 26%, pheterogeneity D
0.25) was observed (Supplemental Figure 19).
In the dose-response meta-analysis, each additional daily
100 g of red meat were positively associated with risk of CHD
(RR: 1.15; 95% CI 1.08 to 1.23, I2 D 0%, pheterogeneity D 0.68,
n D 3), stroke (RR: 1.12; 95% CI 1.06 to 1.17, I2 D 0%, pheteroge-
neity D 0.50, n D 7), and HF (RR: 1.08; 95% CI 1.02 to 1.14,
I2 D 4%, pheterogeneity D 0.37, n D 4) (Supplemental Figure 20).
No evidence of heterogeneity was detected between sub-
groups in stratiﬁed analyses on red meat and stroke. The
observed positive association between red meat intake and
stroke risk was not seen in studies including both women and
men, short-term studies, European studies and studies includ-
ing <1,000 stroke cases (Supplemental Table 23a-b).
There was evidence of a non-linear dose-response associa-
tion between red meat and CHD (pnon-linearity<0.01, nD 2 stud-
ies), and HF (pnon-linearity D 0.02, n D 3 studies), but not for
stroke (pnon-linearity D 0.91, n D 6 studies). The risk of CHD,
stroke, and HF increased by approximately 10–20% with
increasing intake of red meat up to »100 g/d (Figure 2, 3, and
Supplemental Figure 36).
Processed meat
For processed meat, 5 studies with 7,038 cases were included in
the high vs. low intake meta-analysis (overall intake range: 0–
150 g/d) for CHD, 6 studies with 9,492 cases (overall intake
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range: 0–85 g/d) for stroke, and 3 studies with 7,077 cases
(overall intake range: 12–90 g/d) for HF.
Comparing the highest to the lowest categories, a positive
association between processed meat intake and risk of CHD (RR:
1.15; 95% CI 0.99 to 1.33, I2 D 44%, pheterogeneity D 0.13), stroke
(RR: 1.16; 95% CI 1.07 to 1.26, I2 D 12%, pheterogeneity D 0.34),
and HF (RR: 1.27; 95% CI 1.14 to 1.41, I2 D 0%, pheterogeneity D
0.87) was observed (Supplemental Figure 21).
Each additional daily 50 g of processed meat were positively
associated with risk of CHD (RR: 1.27; 95% CI 1.09 to 1.49, I2 D
0%, pheterogeneity D 0.51, n D 3), stroke (RR: 1.17; 95% CI 1.02 to
1.34, I2 D 56%, pheterogeneity D 0.05, n D 6), and HF (RR: 1.12;
95% CI 1.05 to 1.19, I2 D 0%, pheterogeneity D 0.62, n D 2)
(Supplemental Figure 22).
Referring to stroke, there was evidence of heterogeneity in
subgroups stratiﬁed for geographical location, showing a stron-
ger association in studies conducted in America compared to
studies conducted in Europe (pheterogeneity D 0.02; Supplemental
Table 24a-b).
There was no evidence of a non-linear dose-response
association between processed meat and CHD (pnon-linearity
D 0.41, n D 2 studies), stroke (pnon-linearity D 0.65, n D 6
studies), or HF (pnon-linearity D 0.62, n D 2 studies). The
risk of stroke increased by approximately 15% (Figure 3),
and the risk of HF by 25% with increasing intake of proc-
essed meat up to »70 g/d (Figure 3, and Supplemental
Figure 37). No associations were observed for processed
meat and CHD (Figure 2).
Sugar-sweetened beverages
Five studies with 8,740 cases were included in the high vs. low
intake meta-analysis for SSB and CHD (overall intake range: 0–
650 g/d), 7 studies with 11,187 cases for stroke (overall intake
range: 0–2500 g/d), and 2 studies with 8,603 cases for HF (over-
all intake range: 0–625 g/d).
Comparing the highest to the lowest categories, a positive asso-
ciation between SSB intake and risk of CHD (RR: 1.10; 95% CI
1.01 to 1.20, I2 D 50%, pheterogeneity D 0.09) and stroke (RR: 1.09;
95% CI 1.01 to 1.18, I2 D 0%, pheterogeneity D 0.43), but no associa-
tion with HF risk (RR: 1.11; 95% CI 0.88 to 1.39, I2D 81%, phetero-
geneityD 0.02) were observed (Supplemental Figure 23).
Each additional daily 250 ml of SSB were positively associ-
ated with risk of CHD (RR: 1.17; 95% CI 1.11 to 1.23, I2 D 0%,
pheterogeneity D 0.66, n D 4), stroke (RR: 1.07; 95% CI 1.02 to
1.12, I2 D 0%, pheterogeneity D 0.59, n D 6), and HF (RR: 1.08;
95% CI 1.05 to 1.12, n D 1) (Supplemental Figure 24).
Referring to stroke, the positive association with SSB intake
was no longer statistically signiﬁcant in studies including
women or both women and men, in an Asian and Australian
study and in a study including <1,000 stroke cases. However,
no evidence for subgroup-differences was observed (Supple-
mental Table 25a-b).
There was no evidence of a non-linear dose-response asso-
ciation between SSB and CHD (pnon-linearity D 0.83, n D 4
studies), or stroke (pnon-linearity D 0.83, n D 6 studies). The
risk of CHD increased by approximately 35%, and the risk of
stroke by 16% with increasing intake of SSB up to »500 ml/d
(Figure 2 and 3).
Summary across food groups
Table 1 and 2 show the risk ratios for CHD and stroke from the
non-linear dose-response analyses of the 12 pre-deﬁnded food
groups according to servings/day. Optimal consumption (low-
est serving with signiﬁcant results and no further substantial
change in CHD risk or no further data for higher amounts) of
risk-decreasing foods would result in a 65% reduction in CHD,
and a 40% reduction in stroke risk (calculated by 1¡RRreduced)
compared to non-consumption of these foods.
Furthermore, Table 1 shows that increasing the daily con-
sumption of foods with an inverse relation to risk beyond 3
servings/d of whole grains (90 g/d), 3 servings/d of fruits
(»250 g/d), and 1 serving/d (»100 g/d) of legumes would not
further reduce the risk of CHD.
We could further calculate that a consumption of risk-
increasing food of 2 servings/d of red meat (170 g, RR D
1.20), 2 servings/d of processed meat (60 g, RR D 1.16), and
2 servings/d of SSB (500 ml, RR D 1.16) was associated with
a 60% increased risk of stroke (i:e:;RRincreasedD 1:60) com-
pared to non-consumption. Not consuming these foods would
reduce the risk of stroke of about 38% (calculated
by 1¡ 1RRincreased).
Risk of bias and sensitivity analysis
The results varied little when including only studies with a
low risk of bias (Supplemental Table 26). In the sensitivity
analysis for linear dose-response meta-analysis, ﬁndings
including studies with low risk of bias suggested a weaker
inverse association for intake of fruits and a stronger
inverse association for whole grain intake regarding risk of
CHD. The inverse association between ﬁsh intake and CHD
was not longer signiﬁcant in the linear dose-response meta-
analysis including studies with low risk of bias. For risk of
stroke, stronger inverse associations were also observed for
intake of fruits and ﬁsh.
In the sensitivity analyses excluding the three identiﬁed
nested-case control studies (Neelakantan et al. 2016; Wennberg
et al. 2011; Wennberg et al. 2007), and studies reporting odds
ratios (Holmberg et al. 2009; Wennberg et al. 2011; Wennberg
et al. 2007) no changes in the results of the main analysis were
detected.
Quality of meta-evidence
We rated the quality of meta-evidence for the 12 food
groups regarding risk of CHD, stroke and HF. The Nutri-
Grade meta-evidence grading regarding CHD was rated
“low” for reﬁned grains, and eggs and “moderate” for the
10 other food groups. The NutriGrade meta-evidence grad-
ing regarding stroke was rated “low” for whole grains,
reﬁned grains, nuts, and legumes and “moderate” for the
eight other food groups. Regarding HF, the NutriGrade
meta-evidence grading was rated “very low” for reﬁned
grains and “low” for whole grains, vegetables, fruits, nuts,
dairy, and SSB and “moderate” for eggs, ﬁsh, red meat, and
processed meat (Supplemental Table 27a-c).
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Discussion
The associations between 12 a priori deﬁned food groups and risk
of CHD, stroke, and HF were systematically assessed in this meta-
analysis through comparison of the highest to the lowest categories
and dose-response analyses both for linear and non-linear rela-
tionships. In the linear dose-response meta-analysis, an inverse
association was present for whole grain (CHD, HF), vegetable
(CHD, stroke, HF), fruit (CHD, stroke), nut (CHD), legumes
(CHD), and ﬁsh (CHD, stroke, HF) consumption, while a positive
association was present for egg (HF), dairy (HF), red meat (CHD,
stroke, HF), processed meat (CHD, stroke, HF), and SSB (CHD,
stroke, HF) consumption. There was clear indication for non-lin-
earity between intake of whole grains, fruits, nuts, dairy, red meat
and risk of CHD, and intake of vegetables and risk of stroke. The
NutriGrade tool for evaluating the meta-evidence suggested a
moderate conﬁdence in the effect estimate for eggs, dairy, ﬁsh, red
meat, and processed meat with respect to all three outcomes
simultaneously; the conﬁdence in the effect estimate for the other
relationships was lower. The maximum moderate quality of evi-
dence implies that further research could or will add evidence on
the conﬁdence and may change the effect estimate.
Our ﬁndings are in line with previous meta-analyses con-
ducted mostly on single food groups and not synoptically for
12 food groups and often not separately for individual CVD
outcomes. Moreover, this is to our knowledge, the ﬁrst meta-
analysis that investigated the association between whole grain
intake and HF, showing an inverse association. The observed
inverse association between whole grain intake and risk of
CHD is consistent with results from previous meta-analyses on
CHD (Anderson et al. 2000; Aune et al. 2016b; Mellen, Walsh,
and Herrington 2008; Mente et al. 2009; Tang et al. 2015). The
essential nutrients along with the phytonutrients and ﬁbre pres-
ent in whole grains may synergistically contribute to their bene-
ﬁcial effects. A number of mechanisms have been suggested for
the risk reduction associated with whole grains; for example,
reduction of LDL-cholesterol concentrations through soluble
ﬁber; the antioxidant and anti-inﬂammatory properties, possi-
bly due to the presence of polyphenols and other phytonu-
trients; modulation of blood glucose and insulin responses,
improving vascular function and blood pressure, and weight
control (Jonnalagadda et al. 2011).
For vegetables and fruits, our results are similar to previous
meta-analyses that revealed an inverse association between
Table 1. Relative risks from non-linear dose-response analysis of 12 pre-deﬁned food groups and risk of coronary heart disease according to intakes of servings/day. NA,
not applicable.
Food group Risk Ratio (RR), 95% CI
Inverse association
Servings per day 0 1 2 3 4 5 6
Whole grains (1 serving D 30 g/d) 1.00 0.91 (0.88, 0.95) 0.86 (0.80, 0.92) 0.83 (0.78, 0.90) 0.83 (0.77, 0.89) 0.83 (0.77, 0.90) 0.83 (0.77, 0.91)
Vegetables (1 serving D 80 g/d) 1.00 0.96 (0.94, 0.98) 0.92 (0.89, 0.96) 0.90 (0.86, 0.94) 0.88 (0.84, 0.93) 0.88 (0.83, 0.92) 0.87 (0.82, 0.92)
Fruit(1 servingD 80 g/d) 1.00 0.89 (0.86, 0.93) 0.84 (0.80, 0.89) 0.83 (0.79, 0.89) 0.83 (0.79, 0.89) 0.86 (0.75, 0.96) NA
Nuts (1 servingD 28 g/d) 1.00 0.84 (0.73, 0.97) NA NA NA NA NA
Legumes (1 servingD 100 g/d) 1.00 0.89 (0.81, 0.97) 0.90 (0.81, 1.01) NA NA NA NA
Dairy (1 serving D 200 g/d) 1.00 0.96 (0.92, 0.99) 0.96 (0.92, 1.01) 1.02 (0.96, 1.07) NA NA NA
Fish (1 serving D 100 g/d) 1.00 0.91 (0.86, 0.96) 0.87 (0.78, 0.97) 0.83 (0.70, 0.98) NA NA NA
Positive association
SSB (1 serving D 250ml/d) 1.00 1.15 (1.07, 1.23) 1.36 (1.19, 1.57) NA NA NA NA
No association
Reﬁned grains (1 servingD 30 g/d) 1.00 0.99 (0.94, 1.04) 0.99 (0.90, 1.08) 0.99 (0.88, 1.12) 1.01 (0.88, 1.17) 1.04 (0.90, 1.20) 1.10 (0.94, 1.27)
Eggs (1 serving D 55 g/d) 1.00 1.02 (0.96, 1.09) NA NA NA NA NA
Red meat (1 servingD 85 g/d) 1.00 1.09 (0.98, 1.20) NA NA NA NA NA
Processed meat (1 serving D 30 g/d) 1.00 1.11 (0.94, 1.31) NA NA NA NA NA
Table 2. Relative risks from non-linear dose-response analysis of 12 pre-deﬁned food groups and risk of stroke according to intakes of servings/day. NA, not applicable.
Food group Risk Ratio (RR), 95% CI
Inverse association
Servings per day 0 1 2 3 4 5 6
Vegetables (1 serving D 80 g/d) 1.00 0.93 (0.90, 0.97) 0.90 (0.84, 0.95) 0.90 (0.84, 0.95) 0.91 (0.85, 0.97) 0.92 (0.84, 1.01) NA
Fruit (1 serving D 80 g/d) 1.00 0.86 (0.83, 0.89) 0.80 (0.77, 0.85) 0.80 (0.74, 0.86) 0.80 (0.72, 0.88) 0.81 (0.68, 0.96) NA
Dairy (1 serving D 200 g/d) 1.00 0.98 (0.95, 1.00) 0.96 (0.92, 1.00) 0.95 (0.91, 1.00) 0.95 (0.91, 1.00) 0.96 (0.91, 1.01) NA
Fish (1 serving D 100 g/d) 1.00 0.89 (0.79, 1.00) NA NA NA NA NA
Positive association
Red meat (1 servingD 85 g/d) 1.00 1.10 (1.03, 1.16) 1.20 (1.10, 1.31) NA NA NA NA
Processed meat (1 serving D 30 g/d) 1.00 1.13 (1.06, 1.21) 1.16 (1.04, 1.28) NA NA NA NA
SSB (1 serving D 250ml/d) 1.00 1.07 (1.01, 1.13) 1.16 (1.06, 1.26) NA NA NA NA
No association
Whole grains (1 serving D 30 g/d) 1.00 0.97 (0.90, 1.03) 0.95 (0.87, 1.04) 0.93 (0.80, 1.07) 0.92 (0.79, 1.08) 0.92 (0.78, 1.09) 0.93 (0.79, 1.10)
Reﬁned grains (1 servingD 30 g/d) 1.00 1.00 (0.98, 1.02) 0.99 (0.95, 1.04) 0.99 (0.93, 1.05) 0.99 (0.92, 1.06) 0.98 (0.92, 1.06) 0.98 (0.91, 1.06)
Nuts (1 servingD 28 g/d) 1.00 1.07 (0.93, 1.22) NA NA NA NA NA
Legumes (1 servingD 100 g/d) 1.00 0.98 (0.86, 1.11) NA NA NA NA NA
Eggs (1 serving D 55 g/d) 1.00 0.99 (0.92, 1.06) NA NA NA NA NA
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intake and CHD (Gan et al. 2015; Mente et al. 2009) (Dauchet
et al. 2006; He et al. 2007), and stroke risk (Aune et al. 2017; He
et al. 2006; Hu et al. 2014). While we detected no further risk
reduction beyond intake of 250 g fruits per day, another current
meta-analysis showed reductions in risk up to 800 g per day.
This difference could be explained by the greater number of
studies (due to inclusion of studies on cause-speciﬁc mortality
and overall CVD) included by Aune et al. (Aune et al. 2017).
Vegetables and fruits, like the nutrients and phytochemicals
therein, inﬂuence not only inﬂammatory processes, but also
cellular redox processes as well as endothelial and metabolic
processes; it is assumed that these mechanisms are primarily
responsible for the risk-reducing association between vegetable
and fruit consumption and risk of cardiovascular and other dis-
eases (Boeing et al. 2012).
We observed a trend for a strong inverse association
between nut consumption and risk of CHD. In line with
this, previous analyses found that higher nut consumption
is associated with reduced CHD risk (Afshin et al. 2014;
Aune et al. 2016a; Kelly and Sabate 2006; Ma et al. 2014;
Mayhew et al. 2016; Mente et al. 2009; Weng et al. 2016).
An umbrella review found an inverse association of nut
intake and risk of CVD, hypertension, and lower levels of
total cholesterol and LDL-cholesterol. Plausible mechanisms
how the consumption of nuts can affect cardiovascular risk
are through their content of unsaturated fatty acids, protein,
ﬁber, vitamin E, potassium, magnesium, and phytochemicals
(Schwingshackl et al. 2017d).
Despite the absence of a linear association between legumes
and investigated outcomes, the non-linear analysis showed a
10% reduction in CHD risk when consuming up to 100 g/d.
Results from previous analyses provide moderate evidence for a
beneﬁt on CHD (Afshin et al. 2014; Lou et al. 2016; Marven-
tano et al. 2017; Yan et al. 2017). Legumes are good sources of
ﬁber, protein, and some bioactive compounds such as phytos-
terols. These components have shown inverse associations with
total cholesterol, triacylglycerol and LDL-cholesterol concen-
trations, and a positive association with HDL-cholesterol con-
centrations in pooled analyses of intervention trials (Anderson
and Bush 2011). Other bioactive compounds in legumes are
protein-derived bioactive peptides that have been found to
have blood pressure- and cholesterol-lowering effects, as well
as antithrombotic and antioxidant activities in in vitro studies
(Malaguti et al. 2014).
We observed a positive association between egg consump-
tion and HF risk, as is the case in another current analysis
based on the same 4 cohort studies, but not performing dose-
response analysis (Khawaja et al. 2017). Eggs are a major source
of dietary choline and consumption results in increased expo-
sure to trimethylamine-N-oxide, a metabolite linked to athero-
sclerosis (Miller et al. 2014; Senthong et al. 2016). At the same
time, egg yolks are a source of bioavailable xanthophyll carote-
noids with anti-inﬂammatory, anti-oxidative and anti-athero-
sclerotic effects that may possibly promote cardiovascular
health (Clayton et al. 2017). Because deﬁnite mechanisms of
possible effects of eggs and observed relationships are not clear
and vary regarding individual outcomes, respectively, the asso-
ciation between egg consumption and HF should be interpreted
with caution.
Authors of a previous meta-analysis suggested an inverse
association between dairy products consumption and risks of
CHD and stroke, but demanded additional data to more com-
prehensively examine potential dose-response patterns (Alex-
ander et al. 2016). In linear dose-response analysis we observed
an 8% increased HF risk by each additional daily 200 g of dairy.
Despite the absence of a linear association between dairy intake
and stroke, the non-linear analysis showed a 5% reduction in
stroke risk when consuming up to 500 g/d. A recent meta-anal-
ysis observed no association between dairy intake and CHD
incidence, too (Gholami et al. 2017). Dairy products are a rich
source of minerals, such as calcium, vitamins and protein; all of
these nutrients may have a beneﬁcial effect on cardiovascular
health. Otherwise, dairy products contain saturated fatty acids,
and the potential role of saturated fatty acids and cardiovascu-
lar health is controversial (Mozaffarian 2016). Furthermore,
there is some evidence that dairy products, especially those that
are fermented, are associated with reduced risk of adiposity
(Schwingshackl et al. 2016b). Due to inconclusive ﬁndings, rec-
ommendations on dairy consumption relating to cardiovascu-
lar health can-not be given yet.
Our analysis conﬁrmed the well-established risk-decreasing
potential of ﬁsh on CHD (Leung Yinko et al. 2014; Mente et al.
2009; Whelton et al. 2004), on stroke (Bouzan et al. 2005;
Chowdhury et al. 2012; He et al. 2004; Larsson and Orsini
2011; Xun et al. 2012), and on HF (Djousse et al. 2012; Li et al.
2013). The non-linear analyses showed that CHD risk was
reduced by 15% with increasing ﬁsh consumption up to 250 g/
d and a 10 and 20% reduction in risk of stroke and HF, respec-
tively, with up to 80–100 g/d. This association is biologically
plausible through effects of long chain n-3 poly-unsaturated
fatty acids, which are abundant in fatty ﬁsh and have been asso-
ciated with anti-atherosclerotic and anti-thrombotic effects
(Chapkin et al. 2007; Saravanan et al. 2010). In observational
studies, very-long chain n-3 poly-unsaturated fatty acids can be
used as valid markers for habitual ﬁsh intake (Amiano et al.
2001). With this in mind, a large meta-analysis of observational
studies showed that circulating long-chain n-3 poly-unsatu-
rated fatty acids were associated with lower risk of coronary
disease (Chowdhury et al. 2014). Although, the risk-decreasing
potential of ﬁsh is well established and conﬁrmed by the results
of our meta-analysis, the unavoidable presence of environmen-
tal contaminants (Domingo 2016) and aspects of sustainability
should be also taken into account, if larger amounts were
consumed.
We observed positive associations between red meat intake
and CHD, stroke, and HF risk. Consuming red meat up to
150 g/d is associated with a 10–20% increased risk in non-linear
dose-response analyses. Furthermore, we observed positive
associations between processed meat intake and stroke, and HF
risk. The non-linear analyses showed a 15% and 25% increased
risk of stroke and HF, respectively, consuming processed meat
up to 70 g/d. A positive association has been previously
reported between consumption of red and especially processed
meat and CHD and stroke risk, but, to our knowledge, it has
not been reported on HF risk (Chen et al. 2013; Kaluza et al.
2012; Mente et al. 2009; Micha et al. 2012; Micha et al. 2010;
Yang et al. 2016). Unfavorable associations with food groups
such as red and processed meat might be based upon pro-
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inﬂammatory or pro-oxidative compounds, triggered by nitros-
amines, iron, or saturated fatty acids (Mozaffarian 2016).
There is evidence that SSB intake is related to vascular risk
factors, whereas associations with CVD were less consistent
(Keller et al. 2015) and possibly a consequence of SSB con-
sumption being a surrogate for adverse health behaviours
(Narain et al. 2016). Our meta-analyses add moderate evidence
for a risk-increasing association between SSB intake and CHD
and stroke. The non-linear analyses show a 35% increased risk
of CHD and a 16% increased risk of stroke by consuming up to
500 ml/d. The risk-increasing association observed for SSB may
be partly attributed to impairments of the otherwise working
regulation of hunger and satiety (DiMeglio and Mattes 2000).
Evidence of a positive association between SSB consumption
and weight gain and obesity in adults is strong (Malik et al.
2013); obesity is an important risk factor for CVD.
The results of the present meta-analysis add further scien-
tiﬁc evidence supporting the inclusion of some food groups
into food-based dietary guidelines aimed at CVD prevention.
Optimal consumption of whole grains, vegetables, fruits, nuts,
legumes, dairy, and ﬁsh was associated with a 65% reduced risk
of CHD and optimal consumption of vegetables, fruits, dairy,
and ﬁsh was associated with a 40% stroke reduction. Reducing
the consumption of the risk-increasing food groups red meat,
processed meat, SSB, eggs and dairy in relation to HF is preven-
tive, too.
Our results support current food-based dietary guidelines
that promote the consumption of a dietary pattern that empha-
sizes intake of vegetables, fruits, and whole grains and includes,
among other foods, legumes, nuts and ﬁsh, while it limits intake
of red meat and processed meat and SSB as a “heart healthy”
diet (Eckel et al. 2014; Perk et al. 2012; USDA 2015). Our
results however do not support the recommendation to include
low-fat dairy products. To obtain a complete picture it seems
useful to extend the type of food groups to be considered.
Strengths and limitations
Among the strengths of the present meta-analysis are the a pri-
ori published systematic review protocol (Schwingshackl et al.
2016a), the comprehensive literature search, the large number
of included prospective studies, cases, and food groups. Fur-
thermore, we performed different types of analyses (high vs.
low, linear and non-linear dose-response meta-analyses, sub-
group and sensitivity analyses), which allowed us to detect asso-
ciations where the relation was non-linear and ﬁnd an optimal
consumption with the lowest risk. Finally, it is a strength of this
study that the quality of meta-evidence for each food group
was assessed with the NutriGrade scoring system.
A limitation of this systematic review is that for some of the
included studies, only baseline food intake could be used
(assuming a stable consumption over time). Furthermore, there
was substantial heterogeneity with respect to the analyzed pop-
ulation size, follow-up length, baseline age, and food consump-
tion. We conducted subgroup analyses for sex, length of
follow-up, geographic location, number of cases, and dietary
assessment methods to explore high degrees of statistical het-
erogeneity. Overall, for most food groups high levels of statisti-
cal heterogeneity persisted in subgroup analyses. People with a
high intake of whole grains, vegetables, fruits, nuts, legumes or
ﬁsh might have different lifestyles, or socioeconomic status
compared to those with lower intakes, representing important
confounders (Darmon and Drewnowski 2008). However, in
sensitivity analyses including only studies with a low risk of
bias (adjusted for important lifestyle factors: smoking, physical
activity, body mass index), the results of the primary analysis
were conﬁrmed. For most food groups in association with HF,
a very limited amount of studies was found. Therefore, some of
these results should be interpreted with caution. Finally,
another major limitation explaining differences between results
of our and other meta-analyses on speciﬁc food groups could
be that we did not include prospective studies on overall CVD
and on outcome-speciﬁc mortality.
Conclusion
An optimal intake of whole grains, vegetables, fruits, nuts,
legumes, dairy, ﬁsh, red and processed meat, eggs, and SSB
showed an important lower risk of CHD, stroke, and HF. Even
though quality of meta-evidence according to NutriGrade is
moderate, the results of this comprehensive meta-analysis may
serve as key component in deriving food-based dietary guide-
lines for prevention of CVD.
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